Skip to content
Recall Observatory FDA recall evidence

Drug product

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01

D-0247-2021

January 21, 2021

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 87195
Status
Terminated
Classification
Class III
Quantity
46,479 bottles
Official record key
drug-enforcement:D-0247-2021

Official wording

Reason: Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.

Code information: Lot # A906423, exp. date Nov 2021.

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification